Method of forming amino acid-derived diaminopropanols useful as chemical intermediates for protease-inhibitors
AssigneePharm-Eco Laboratories, Inc.
InventorsBiman Pal, Siya Ram, Bing Cai, Yesh P. Sachdeva, Jaechul Shim, Salah A. Zahr, Emile Al-Farhan, Richard L. Gabriel
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of forming a 1,3-diamino-3-substituted-2-propanol chemical intermediate from which various chemicals, such as selected protease-inhibitors and other drugs, as well as polymers, can be synthesized. This method includes contacting a nitromethyl amino acid compound with at least one reducing agent to form the 1,3-diamino-3-substituted-2-propanol chemical intermediate.
Claims10
A method for producing a protease inhibitor synthetic intermediate represented by the formula ##STR13## or salts thereof, wherein:
- R.sup.1 is an amino protecting group;
- R.sup.2 is selected from the group consisting of --H, C1-C18 alkyl, aryl, acetyl and tosyl;
- R.sup.3 is a side-chain of a naturally occurring amino acid or a side chain of a naturally occurring amino acid substituted with a halogen, hydroxyl, sulfonate, C1-C3 alkyl, C1-C3 alkoxy or acyl;
- R.sup.4 and R.sup.5 are each independently selected from the group consisting of --H, alkyl, aryl, nitrile and alkoxycarbonyl;
- and
- each R.sup.6 is independently selected from the group consisting of hydrogen, lower alkyl, halo-substituted lower alkyl, aryl and heteroaralkyl radicals,
- comprising the steps of:
- a) reacting a 1,3-diamino-3-substituted-2-propanol represented by the following structural formula:
- ##STR14## with an aldehyde or a ketone, having the formula R.sup.6 C(O)R.sup.6, in an anhydrous solvent, whereby R.sup.6 C(O)R.sup.6 is condensed to form an imino compound;
- and
- b) reacting said imino compound with an imino reducing agent, whereby the imino compound is reductively aminated, thereby forming said protease inhibitor synthetic intermediate.
A method for producing a protease inhibitor synthetic intermediate represented by the formula ##STR15## and salts thereof, wherein:
- R.sup.1 is a protecting group;
- R.sup.2 is selected from the group consisting of --H, C1-C18 alkyl, aryl, heteroaryl, acetyl and tosyl;
- R.sup.3 is a side-chain of a naturally occurring amino acid or a side chain of a naturally occurring amino acid substituted with a halogen, hydroxyl, sulfonate, C1-C3 alkyl, C1-C3 alkoxy or acyl;
- R.sup.4 and R.sup.5 are each independently selected from the group consisting of --H, alkyl, aryl, nitrile and alkoxycarbonyl;
- and
- each R.sup.10 is independently selected from the group consisting of hydrogen, lower alkyl, halo-substituted lower alkyl, alkaryl, arylalkyl, aryl and heteroaralkyl radicals,
- from a 3-amino-3-substituted-2-oxo-1-nitropropane represented by the following structural formula:
- ##STR16## comprising the steps of:
- a) reacting said 3-amino-3-substituted-2-oxo-1-nitropropane with a carbonyl reducing agent, whereby the carbonyl group is reduced to form a 1-nitro-3-amino-3-substituted-2-propanol compound represented by the following structural formula:
- ##STR17## b) reacting said 1-nitro-3-amino-3-substituted-2-propanol with a nitro reducing agent, whereby the nitro group is reduced to form a first chemical intermediate represented by the following structural formula:
- ##STR18## c) reacting said first chemical intermediate with an aldehyde or a ketone, having a formula R.sup.10 (O)R.sup.10, in an anhydrous solvent, whereby R.sup.10 (O)R.sup.10 is condensed to form an imino compound;
- and
- d) reacting said imino compound with an imino reducing agent whereby the the first chemical intermediate is reductively aminated, thereby forming said protease inhibitor synthetic intermediate.
Dependencies are inferred from the claim text.